logo-loader
CSE:PREV OTCMKTS:PRVCF

PreveCeutical Medical Inc.

Receive alerts
Market:
CSE
Market Cap:
$5.95 m
Price
0.02 CAD
Change
0.00%
52 weeks high
0.08
52 weeks low
0.01

In brief

PreveCeutical is a health sciences company that develops innovative options for preventive and curative therapies utilising organic and nature identical products.

PreveCeutical aims to be a leader in preventive health sciences and currently has five research and development programs, including: dual gene therapy for curative and prevention therapies for diabetes and obesity; the soluble gel drug delivery research and development program; Nature Identical™ peptides for treatment of various ailments; non-addictive analgesic peptides as a replacement to the highly addictive analgesics such as morphine, fentanyl and oxycodone; and a therapeutic product for treating athletes who suffer from concussions (mild traumatic brain injury).

Deep dive We explore the investor case for growth companies

Snapshot

The health sciences company has five research and development programs, including gene therapy, its Sol-gel program for nose-to-brain delivery of medical compounds including cannabinoids, as well as non-addictive analgesic peptides as a replacement for morphine, fentanyl and oxycodone